BioCardia, Inc.

BioCardia is a global leader in the development of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases. Their mission is to improve the lives of patients by developing meaningful therapeutics, with a focus on heart failure and related conditions. The company's biotherapeutic platforms, CardiAMP (autologous) and CardiALLO (allogenic) cell therapies, are used in clinical stage product candidates, offering both patient-specific and donor-derived cell therapies for a variety of heart conditions. BioCardia has also developed the Helix biotherapeutic delivery system, a leading percutaneous catheter delivery system for cardiovascular regenerative medicine, and the Morph vascular navigation product platform, designed to provide advanced access and control for interventional procedures.

BioCardia is dedicated to scientific advancements and strives to provide patients with safe and effective treatment options. Their innovative approach to cardiac regenerative medicine combines cutting-edge technology with a focus on patient safety. They are actively engaged in clinical trials and collaborating with other biotherapeutic companies to expand the use of their delivery systems and therapies. BioCardia's commitment to research and development, coupled with their unique product portfolio, positions them as a key player in the rapidly evolving field of cell-based therapies for cardiovascular disease.

BioCardia, Inc. is a global leader in developing cell and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases. The company is dedicated to improving the lives of patients with unmet medical needs in these areas by creating meaningful therapeutics that address the root causes of these debilitating conditions. BioCardia's mission is to advance innovative and effective therapies that promote the body's natural healing processes and deliver lasting relief for patients suffering from heart and lung diseases.

BioCardia promotes a culture that values teamwork, innovation, and a deep commitment to patient safety. They emphasize a data-driven approach, embracing continuous improvement and open communication. The company encourages a sense of urgency, focusing on efficiency and execution, while simultaneously fostering a positive and supportive environment where employees feel valued and empowered to make a difference in the lives of patients.

BioCardia is committed to fostering a workplace that values diversity, equity, and inclusion. They believe that a diverse team leads to better decision-making, innovation, and overall success. This commitment is reflected in their values, which emphasize respect, open-mindedness, and inclusion. They actively promote a culture of belonging where all employees feel valued and supported, regardless of their background. While specific programs or initiatives are not explicitly stated on their website, the company emphasizes the importance of diversity and inclusion as a core principle.